Nausea - the most common side effect, reported more frequently at higher doses Diarrhoea Vomiting Constipation Abdominal pain or discomfort These side effects were generally mild to moderate in severity and were most common during the dose escalation period (the first 1216 weeks of treatment, when the dose is gradually increased)
Collecting duct water permeability inhibition by EGF is associated with decreased cAMP, PKA activity, and AQP2 phosphorylation at Ser(269)
For about a month, Becerra injected half a milligram a week
This makes it a suitable option for those looking to experience weight loss while also managing a cardiovascular issue
Blue Cross Blue Shield cited high costs and a surge in spending on GLP-1 drugs
The ongoing clinical trial, the Restoring Insulin Secretion (RISE) Consortium, is testing whether placebo, metformin alone, liraglutide plus metformin, or insulin (3 months) followed by metformin (9 months) can preserve or improve beta cell function in individuals with early type 2 diabetes or prediabetes 48